1. Home
  2. RVMD vs CROX Comparison

RVMD vs CROX Comparison

Compare RVMD & CROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • CROX
  • Stock Information
  • Founded
  • RVMD 2014
  • CROX 1999
  • Country
  • RVMD United States
  • CROX United States
  • Employees
  • RVMD N/A
  • CROX N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • CROX Shoe Manufacturing
  • Sector
  • RVMD Health Care
  • CROX Consumer Discretionary
  • Exchange
  • RVMD Nasdaq
  • CROX Nasdaq
  • Market Cap
  • RVMD 8.7B
  • CROX 8.3B
  • IPO Year
  • RVMD 2020
  • CROX 2006
  • Fundamental
  • Price
  • RVMD $41.33
  • CROX $107.60
  • Analyst Decision
  • RVMD Strong Buy
  • CROX Buy
  • Analyst Count
  • RVMD 13
  • CROX 14
  • Target Price
  • RVMD $65.15
  • CROX $140.62
  • AVG Volume (30 Days)
  • RVMD 1.2M
  • CROX 2.0M
  • Earning Date
  • RVMD 02-26-2025
  • CROX 02-13-2025
  • Dividend Yield
  • RVMD N/A
  • CROX N/A
  • EPS Growth
  • RVMD N/A
  • CROX 24.16
  • EPS
  • RVMD N/A
  • CROX 15.88
  • Revenue
  • RVMD $742,000.00
  • CROX $4,102,108,000.00
  • Revenue This Year
  • RVMD N/A
  • CROX $3.87
  • Revenue Next Year
  • RVMD $1,855.56
  • CROX $4.11
  • P/E Ratio
  • RVMD N/A
  • CROX $6.78
  • Revenue Growth
  • RVMD N/A
  • CROX 3.53
  • 52 Week Low
  • RVMD $28.95
  • CROX $88.25
  • 52 Week High
  • RVMD $62.40
  • CROX $165.32
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 44.66
  • CROX 55.83
  • Support Level
  • RVMD $40.13
  • CROX $104.66
  • Resistance Level
  • RVMD $42.68
  • CROX $111.15
  • Average True Range (ATR)
  • RVMD 1.41
  • CROX 3.99
  • MACD
  • RVMD 0.10
  • CROX 1.82
  • Stochastic Oscillator
  • RVMD 26.42
  • CROX 82.76

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About CROX Crocs Inc.

Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include the Americas, Asia Pacific, and EMEA.

Share on Social Networks: